RGT 51.4% 53.0¢ argent biopharma limited

Ann: March Quarterly Activity and Cashflow Report, page-14

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 683 Posts.
    lightbulb Created with Sketch. 270
    You know what, completely forgot about them - not intentional.

    Let's add them in:

    MDC - $1.356mil receipts / $0 manufacturing costs (total loss $3.114mil)
    - $1.528mil staff/administration costs
    - $0 government grant and/or tax incentive

    AGH - $1.488mil receipts / $597k manufacturing costs (total $2.57mil loss)
    - $2.543mil staff/administration costs
    - $0 government grant and/or tax incentive

    CGB are yet to release their quarterly.


    Still the same issue all round, high staff/administration costs and overall total loss.

    So MXC drops a couple more spots to 7th in terms of receipts/sales, but still much lower with staff/administration costs and total loss.

    Anyway thought it'd be good to group them all together so people can have a look at the comparison - and the underlying issue for most cannabis stocks, high burn rates and expenses/cost of sales.
 
watchlist Created with Sketch. Add RGT (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.